Matches in Nanopublications for { ?s ?p "[High GCNs of MET and HGF associate with an increased risk of trastuzumab-based therapy failure in HER2-positive MBC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP296227.RAf6NS78c1WTKyyTMJkp05WP0Yj5Riahqnr-jpH3MN2Rc130_assertion description "[High GCNs of MET and HGF associate with an increased risk of trastuzumab-based therapy failure in HER2-positive MBC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP296227.RAf6NS78c1WTKyyTMJkp05WP0Yj5Riahqnr-jpH3MN2Rc130_provenance.
- NP630975.RAbnkgHA0RQXDwptohxg2z2DvQ3HNCBka6QW4i1psivtg130_assertion description "[High GCNs of MET and HGF associate with an increased risk of trastuzumab-based therapy failure in HER2-positive MBC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP630975.RAbnkgHA0RQXDwptohxg2z2DvQ3HNCBka6QW4i1psivtg130_provenance.
- NP323564.RA0dfbr8Exi7aEbHydUb9OdhuoLJQr-bUjJ7dtKvpTFKY130_assertion description "[High GCNs of MET and HGF associate with an increased risk of trastuzumab-based therapy failure in HER2-positive MBC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP323564.RA0dfbr8Exi7aEbHydUb9OdhuoLJQr-bUjJ7dtKvpTFKY130_provenance.